FDA Inspection
Rovi Pharma Industrial Services S.A.Rovi Pharma Industrial Services S.A. – FDA Inspection, Sep 14, 2018
Record Details
This FDA Inspection record concerns Rovi Pharma Industrial Services S.A., with an inspection on September 14, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · f9cc1e37-79be-44f4-8add-41577e14045d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1066861
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.111Establishment of time limitations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Rovi Pharma Industrial Services S.A.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| January 17, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 2, 2023 | VAI | Office of Inspections and Investigations | |
| April 4, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 2, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 23, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Rovi Pharma Industrial Services S.A.
- FDA Inspection 1260967 - 2024-01-17
- FDA Inspection 1206821 - 2023-06-02
- FDA Inspection 885444 - 2014-04-04
- FDA Inspection 765637 - 2012-02-02
- FDA Inspection 582975 - 2009-04-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.